Cite
SLFN11 promotes clear cell renal cell carcinoma progression via the PI3K/AKT signaling pathway.
MLA
Wang, He-Xi, et al. “SLFN11 Promotes Clear Cell Renal Cell Carcinoma Progression via the PI3K/AKT Signaling Pathway.” Medical Oncology (Northwood, London, England), vol. 41, no. 2, Jan. 2024, p. 54. EBSCOhost, https://doi.org/10.1007/s12032-023-02262-9.
APA
Wang, H.-X., Zhao, Z.-P., Du, X.-Y., Peng, S.-L., Xu, H.-Y., Tang, W., & Yang, L. (2024). SLFN11 promotes clear cell renal cell carcinoma progression via the PI3K/AKT signaling pathway. Medical Oncology (Northwood, London, England), 41(2), 54. https://doi.org/10.1007/s12032-023-02262-9
Chicago
Wang, He-Xi, Zhi-Peng Zhao, Xiao-Yi Du, Sen-Lin Peng, Hao-Yu Xu, Wei Tang, and Lei Yang. 2024. “SLFN11 Promotes Clear Cell Renal Cell Carcinoma Progression via the PI3K/AKT Signaling Pathway.” Medical Oncology (Northwood, London, England) 41 (2): 54. doi:10.1007/s12032-023-02262-9.